SkinCeuticals’ CUSTOM D.O.S.E – a personalised skincare technology – has been named on Time’s annual list of the 100 Best Inventions.

The serum, which features 12 unique ingredients proven to address the look of skin discolouration and visible signs of ageing, is offered once a skincare professional performs a diagnostic to determine which formula is best suited to each individual’s skin needs.

The entirely personalised corrective serum was developed by L’Oreal’s Technology Incubator in partnership with SkinCeuticals.

Technology and beauty research have combined to help create the D.O.S.E. system, which uses 2,000 algorithms to process personal data before concocting a unique formula, drawing from highly concentrated ingredients like retinol, glycolic acid and niacinamide­.

More than 250 unique skin types were examined in the research development of CUSTOM D.O.S.E to ensure the highest quality and effectively customised therapy. The serum has a production-quality compounder that operates at 1,200 rotations per minute to mix ingredients precisely, drop by drop. The machine uniquely combines active ingredients that have historically been unable to be mixed outside of a factory setting.

Applied once to twice a day, a bottle of the serum lasts approximately three months, at which time the serum is adjusted based on the skin’s progress, seasonal changes and planned aesthetic procedures.

Christina Fair, Head of SkinCeuticals U.S, said, “CUSTOM D.O.S.E has opened the brand to not only be the leader in medical skincare, but a leader in technological innovation. Our physicians are able to provide a service from SkinCeuticals that is unique to them that grows and retain patients.”

To create the 2019 Best Inventions list, TIME solicited nominations across a variety of categories from editors and correspondents around the world, as well as through an online application process. Each contender was then evaluated on key factors including originality, effectiveness, ambition and influence. 

SkinCeuticals’ CUSTOM D.O.S.E is expected to launch in Australia in 2020.


For more news and updates, subscribe to our weekly newsletter.